The Lotus Health AI doctor is betting big on a radical idea: primary healthcare that’s free, AI-driven, and available 24/7. On Tuesday, Lotus Health AI announced it has raised $35 million in Series A funding, bringing its total capital to $41 million.

The round was co-led by CRV and Kleiner Perkins, signaling strong investor confidence in AI-led healthcare models.

From Chatbots to Real Medical Care

Many people already turn to OpenAI’s ChatGPT and other large language models for medical advice. The Lotus Health AI doctor goes further—transforming those conversations into actual medical care, including diagnoses, prescriptions, lab orders, and specialist referrals.

Founded by KJ Dhaliwal, who previously sold the dating app Dil Mil for $50 million, Lotus Health AI operates as a licensed primary care provider in all 50 U.S. states, supports 50 languages, and carries malpractice insurance with full HIPAA compliance.

How the Lotus Health AI Doctor Works

At its core, the Lotus Health AI doctor functions like a real medical practice—except most of the initial clinical work is done by AI.

The system:

• Asks patients the same structured questions a physician would
• Synthesizes patient history with the latest evidence-based research
• Generates treatment plans, prescriptions, and referrals

To mitigate the risk of AI hallucinations, every diagnosis, lab order, and prescription is reviewed and signed off by board-certified human doctors from institutions such as Stanford University, Harvard University, and UCSF.

“AI is giving the advice, but the real doctors are actually signing off on it,” Dhaliwal said.

Knowing AI’s Limits in Healthcare

Lotus is clear-eyed about what virtual care can’t do. For emergencies or urgent conditions, the Lotus Health AI doctor directs patients to nearby urgent care centers or emergency rooms. Cases requiring physical exams are referred to in-person physicians.

This hybrid approach allows Lotus to scale care while staying within medical and regulatory boundaries.

Why Investors Are Betting on an AI Doctor

Healthcare regulation is notoriously complex, especially in the U.S., where physicians are licensed state by state. Still, Saar Gur, general partner at CRV and a new board member at Lotus, believes the timing is right.

Telemedicine frameworks built during the pandemic—and recent AI breakthroughs—have lowered many historical barriers.

“It’s a big swing,” Gur said. “But that’s the point.”

Solving the Primary Care Shortage

With primary care doctors in short supply, Lotus claims its AI-first model can see up to 10 times more patients than a traditional practice, even while capping visits at 15 minutes.

The startup competes with other AI-doctor platforms, including Lightspeed-backed Doctronic. For now, Lotus is differentiating itself with a bold promise: everything is free.

Dhaliwal says future monetization could include subscriptions or sponsored content—but revenue is not the focus today.

“Our priority is product quality and patient trust,” he said.

A High-Risk, High-Impact Bet on AI Healthcare

If the Lotus Health AI doctor succeeds, it could fundamentally reshape primary care—shifting it from scarcity-driven access to always-on, AI-augmented medicine.

In a healthcare system stretched thin, that’s a bet many patients—and investors—are watching closely.

Don’t miss out on our latest news—follow us for the latest AI news, breakthroughs, and insights that matter.